The Pharmaceutical Research and Manufacturers of America offered "tepid support" for the program but others worry about "Big Brother,"
"vigilantism," or "personal jihads," Thomaselli reports.
"It's a bit of a publicity stunt that is going to make the agency look bad in the long run," says Peter Pitts, former FDA
associate commissioner and global head of regulatory and public policy for Omnicom Group's Porter Novelli. One potential problem is that there no way to assure that a misleading ad actually comes from
a health professional.
The FDA is also running a Web-based campaign to educate consumers about false or misleading DTC ads called EthicAd.
advertisement
advertisement